Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re-Reference-Cited by-同舟云学术

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re

Published:2014-11 Issue: Volume:87 Page:519-528
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Altai Mohamed,Honarvar Hadis,Wållberg Helena,Strand Joanna,Varasteh Zohreh,Rosestedt Maria,Orlova Anna,Dunås Finn,Sandström Mattias,Löfblom John,Tolmachev Vladimir^ORCID,Ståhl Stefan

Funder

Swedish Cancer Society (Cancerfonden)

Swedish Research Council (Vetenskapsrådet)

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference55 articles.

1. Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance;Bailey;J. Carcinog.,2011

2. Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab;Brand;Cancer Biol. Ther.,2011

3. Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors;Giaccone;Cancer Treat. Rev.,2011

4. Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers–role of estrogen receptor and HER2 reactivation;Wang;Breast Cancer Res.,2011

5. Strategies to overcome resistance to targeted protein kinase inhibitors;Daub;Nat. Rev. Drug Discov.,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands;Pharmaceuticals;2024-02-16

2. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody;European Journal of Nuclear Medicine and Molecular Imaging;2024-01-13

3. The use of liposomes functionalized with the NFL-TBS.40–63 peptide as a targeting agent to cross the in vitro blood–brain barrier and target glioblastoma cells;International Journal of Pharmaceutics;2023-11

4. Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3;Nuclear Medicine and Biology;2023-09

5. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer;Frontiers in Oncology;2022-06-15